| At baseline in ReAct | At baseline in ReAlise | ||
---|---|---|---|---|
Parameter | n | Value | n | Value |
Age, y, mean (SD) | 6,610 | 53.7 (13.0) | 3,435 | 54.5 (12.5) |
Female, n (%) | 6,610 | 5,332 (80.7) | 3,435 | 2,724 (79.3) |
Duration of RA, y, mean (SD) | 6,572 | 10.8 (8.6) | 3,423 | 12.0 (8.6) |
Rheumatoid factor positive, n (%) | 6,610 | 4,811 (72.8) | 3,429 | 2,548 (74.2)* |
DMARD use at baseline, n (%) | 6,610 | 4,879 (73.8) | 3,435 | 2,636 (76.7)* |
SJC (28), mean (SD) | 6,607 | 10.4 (5.8) | 3,435 | 2.2 (3.4) |
TJC (28), mean (SD) | 6,607 | 13.5 (7.0) | 3,435 | 3.2 (4.7) |
PtGA, mm VAS, mean (SD) | 6,568 | 61.9 (21.4) | 3,256 | 26.2 (23.3) |
DAS28 (ESR), mean (SD) | 6,554 | 6.0 (1.1) | 2,729 | 3.5 (1.3) |
HAQ DI, mean (SD) | 6,560 | 1.64 (0.68) | 3,235 | 0.89 (0.74) |
CRP, mg/L, mean (SD) | 6,535 | 25.7 (30.8) | 2,962 | 9.5 (15.7) |